PubRank

P J Spiess

Author PubWeight™ 37.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 1998 11.03
2 Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2. J Exp Med 1985 3.05
3 Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 1987 3.03
4 Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes. J Exp Med 1991 2.14
5 Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine. J Immunol 1999 1.71
6 In vitro growth of murine T cells. I. Production of factors necessary for T cell growth. J Immunol 1978 1.55
7 Insertion signal sequence fused to minimal peptides elicits specific CD8+ T-cell responses and prolongs survival of thymoma-bearing mice. Cancer Res 1994 1.48
8 A simplified method for the production of murine T-cell growth factor free of lectin. J Immunol Methods 1981 1.42
9 In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors. J Immunol 1980 1.39
10 A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability. J Exp Med 1992 1.39
11 Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action. J Exp Med 1990 1.28
12 In vitro growth of murine T cells. II. Growth of in vitro sensitized cells cytotoxic for alloantigens. J Immunol 1978 1.09
13 Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes. J Natl Cancer Inst 1988 1.04
14 In vivo administration of Interleukin-2 enhances specific alloimmune responses. Transplantation 1983 1.04
15 Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. Cancer Res 1986 0.94
16 In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. J Biol Response Mod 1990 0.93
17 In vitro growth of murine T cells. IV. Use of T-cell growth factor to clone lymphoid cells. Cell Immunol 1980 0.92
18 Minimal determinant expressed by a recombinant vaccinia virus elicits therapeutic antitumor cytolytic T lymphocyte responses. Cancer Res 1995 0.90
19 Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer. Pathol Oncol Res 1999 0.83
20 In vitro growth of murine T cells. III. Method for separation of T cell growth factor (TCGF) from concanavalin A and biological activity of the resulting TCGF. J Immunol Methods 1980 0.79
21 Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma. J Natl Cancer Inst 1982 0.75
22 Reduction of preexisting transplantation immunity by specific pregnancy. Transplantation 1973 0.75